about
Somatic STAT3 mutations in large granular lymphocytic leukemiaThe analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia.Differentiation status of primary chronic myeloid leukemia cells affects sensitivity to BCR-ABL1 inhibitors.Somatic mutations in clonally expanded cytotoxic T lymphocytes in patients with newly diagnosed rheumatoid arthritis.Novel drug candidates for blast phase chronic myeloid leukemia from high-throughput drug sensitivity and resistance testing.Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia.Novel somatic mutations in large granular lymphocytic leukemia affecting the STAT-pathway and T-cell activation.Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling.Genomic landscape characterization of large granular lymphocyte leukemia with a systems genetics approachHigh incidence of activating STAT5B mutations in CD4-positive T-cell large granular lymphocyte leukemia.Divergent roles for antigenic drive in the aetiology of primary versus dasatinib-associated CD8+ TCR-Vβ+ expansions.Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL.Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target.Novel TBL1XR1, EPHA7 and SLFN12 mutations in a Sezary syndrome patient discovered by whole exome sequencing.Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemia
P50
Q27851792-7323765D-320F-49F0-9758-31FAF0497B50Q30303161-9004D9D0-CE69-409A-84F6-1990D833007FQ33618407-8743D114-9648-4E32-8EC2-08E9A5CA4AB7Q33827911-C5C33D55-38C9-4F57-9EEA-3025B20D9A7EQ35579430-628301C2-6342-4806-A214-644C0CE1A384Q36889731-03C1B348-C432-4899-B5A6-A233CE438F11Q37423753-76CED3CD-CC3E-48F9-97FA-6F9091CD7E80Q40095304-8100A247-14DD-4145-9517-B1857BAD1341Q42021237-45EBB2A8-90F4-4BB7-BDF2-79736469731BQ42366383-3B8B4A72-8D74-4E1C-AAA8-990F68730D3EQ49276933-7401FF51-1D0F-41B8-8B72-97874FB76E49Q49959048-A8AB1E7A-D454-40C3-B6C6-D92BA3B256A8Q52718168-7ED43752-8082-4B97-AC98-8DDC95E71329Q53059753-8E76D5B3-E452-4E77-963E-65804C28CE82Q56965905-719393E0-4EBA-4FB9-8719-6AFEF6283152
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Emma I Andersson
@ast
Emma I Andersson
@en
Emma I Andersson
@es
Emma I Andersson
@nl
type
label
Emma I Andersson
@ast
Emma I Andersson
@en
Emma I Andersson
@es
Emma I Andersson
@nl
prefLabel
Emma I Andersson
@ast
Emma I Andersson
@en
Emma I Andersson
@es
Emma I Andersson
@nl
P106
P21
P31
P496
0000-0002-3986-9892